Asian consensus on assessment and management of mild to moderate plaque psoriasis with topical therapy

Shinichi Imafuku, Min Zheng, Yayoi Tada, Xibao Zhang, Colin Theng, Suganthi Thevarajah, Yi Zhao, Hae Jun Song

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

A working group of dermatologists in Asian countries assessed the current status of psoriatic management in the region to prepare a consensus report on topical treatment in mild to moderate plaque psoriasis. Even though the association of psoriasis with systemic comorbidities is increasingly acknowledged, psoriasis is still lower in health-care priority lists in the region. The psychosocial impact of psoriasis may be greater in Asian countries due to cultural norms and social discrimination. Non-adherence to treatment is also common among Asians. The current care given to patients with mild to moderate psoriasis needs to be streamlined, enhanced and organized with a patient-centered care approach to achieve better outcomes. A comprehensive assessment of the disease severity and its impact on a patient's life is required before initiating treatment. Education and active involvement of the patient in the treatment plan is an important part of psoriatic management. It is recommended to personalize topical treatment to meet the needs of the patient, depending on disease severity, psychosocial impact, the patient's expectations and, more importantly, the patient's willingness and ability to actively follow the treatment procedure. Fixed-dose combination of corticosteroid and vitamin D analogs is the preferred topical medication for both initial and maintenance phases of treatment. The fast containment of the disease is the goal of the initial phase of 4-8 weeks and it demands a potent fast-acting topical therapy. Satisfactory control of the disease and prevention of relapses should be achieved during the maintenance phase with twice a week or weekend applications.

Original languageEnglish
JournalJournal of Dermatology
DOIs
Publication statusAccepted/In press - 2018 Jan 1

Fingerprint

Psoriasis
Consensus
Therapeutics
Social Discrimination
Maintenance
Health Priorities
Patient-Centered Care
Aptitude
Secondary Prevention
Vitamin D
Comorbidity
Adrenal Cortex Hormones
Delivery of Health Care
Education

Keywords

  • Asia
  • Consensus
  • Patient-centered care
  • Psoriasis
  • Topical therapy

ASJC Scopus subject areas

  • Dermatology

Cite this

Asian consensus on assessment and management of mild to moderate plaque psoriasis with topical therapy. / Imafuku, Shinichi; Zheng, Min; Tada, Yayoi; Zhang, Xibao; Theng, Colin; Thevarajah, Suganthi; Zhao, Yi; Song, Hae Jun.

In: Journal of Dermatology, 01.01.2018.

Research output: Contribution to journalArticle

Imafuku, Shinichi ; Zheng, Min ; Tada, Yayoi ; Zhang, Xibao ; Theng, Colin ; Thevarajah, Suganthi ; Zhao, Yi ; Song, Hae Jun. / Asian consensus on assessment and management of mild to moderate plaque psoriasis with topical therapy. In: Journal of Dermatology. 2018.
@article{fb088b17cb3d4e6cb42779609238d14d,
title = "Asian consensus on assessment and management of mild to moderate plaque psoriasis with topical therapy",
abstract = "A working group of dermatologists in Asian countries assessed the current status of psoriatic management in the region to prepare a consensus report on topical treatment in mild to moderate plaque psoriasis. Even though the association of psoriasis with systemic comorbidities is increasingly acknowledged, psoriasis is still lower in health-care priority lists in the region. The psychosocial impact of psoriasis may be greater in Asian countries due to cultural norms and social discrimination. Non-adherence to treatment is also common among Asians. The current care given to patients with mild to moderate psoriasis needs to be streamlined, enhanced and organized with a patient-centered care approach to achieve better outcomes. A comprehensive assessment of the disease severity and its impact on a patient's life is required before initiating treatment. Education and active involvement of the patient in the treatment plan is an important part of psoriatic management. It is recommended to personalize topical treatment to meet the needs of the patient, depending on disease severity, psychosocial impact, the patient's expectations and, more importantly, the patient's willingness and ability to actively follow the treatment procedure. Fixed-dose combination of corticosteroid and vitamin D analogs is the preferred topical medication for both initial and maintenance phases of treatment. The fast containment of the disease is the goal of the initial phase of 4-8 weeks and it demands a potent fast-acting topical therapy. Satisfactory control of the disease and prevention of relapses should be achieved during the maintenance phase with twice a week or weekend applications.",
keywords = "Asia, Consensus, Patient-centered care, Psoriasis, Topical therapy",
author = "Shinichi Imafuku and Min Zheng and Yayoi Tada and Xibao Zhang and Colin Theng and Suganthi Thevarajah and Yi Zhao and Song, {Hae Jun}",
year = "2018",
month = "1",
day = "1",
doi = "10.1111/1346-8138.14338",
language = "English",
journal = "Journal of Dermatology",
issn = "0385-2407",
publisher = "Wiley-Blackwell",

}

TY - JOUR

T1 - Asian consensus on assessment and management of mild to moderate plaque psoriasis with topical therapy

AU - Imafuku, Shinichi

AU - Zheng, Min

AU - Tada, Yayoi

AU - Zhang, Xibao

AU - Theng, Colin

AU - Thevarajah, Suganthi

AU - Zhao, Yi

AU - Song, Hae Jun

PY - 2018/1/1

Y1 - 2018/1/1

N2 - A working group of dermatologists in Asian countries assessed the current status of psoriatic management in the region to prepare a consensus report on topical treatment in mild to moderate plaque psoriasis. Even though the association of psoriasis with systemic comorbidities is increasingly acknowledged, psoriasis is still lower in health-care priority lists in the region. The psychosocial impact of psoriasis may be greater in Asian countries due to cultural norms and social discrimination. Non-adherence to treatment is also common among Asians. The current care given to patients with mild to moderate psoriasis needs to be streamlined, enhanced and organized with a patient-centered care approach to achieve better outcomes. A comprehensive assessment of the disease severity and its impact on a patient's life is required before initiating treatment. Education and active involvement of the patient in the treatment plan is an important part of psoriatic management. It is recommended to personalize topical treatment to meet the needs of the patient, depending on disease severity, psychosocial impact, the patient's expectations and, more importantly, the patient's willingness and ability to actively follow the treatment procedure. Fixed-dose combination of corticosteroid and vitamin D analogs is the preferred topical medication for both initial and maintenance phases of treatment. The fast containment of the disease is the goal of the initial phase of 4-8 weeks and it demands a potent fast-acting topical therapy. Satisfactory control of the disease and prevention of relapses should be achieved during the maintenance phase with twice a week or weekend applications.

AB - A working group of dermatologists in Asian countries assessed the current status of psoriatic management in the region to prepare a consensus report on topical treatment in mild to moderate plaque psoriasis. Even though the association of psoriasis with systemic comorbidities is increasingly acknowledged, psoriasis is still lower in health-care priority lists in the region. The psychosocial impact of psoriasis may be greater in Asian countries due to cultural norms and social discrimination. Non-adherence to treatment is also common among Asians. The current care given to patients with mild to moderate psoriasis needs to be streamlined, enhanced and organized with a patient-centered care approach to achieve better outcomes. A comprehensive assessment of the disease severity and its impact on a patient's life is required before initiating treatment. Education and active involvement of the patient in the treatment plan is an important part of psoriatic management. It is recommended to personalize topical treatment to meet the needs of the patient, depending on disease severity, psychosocial impact, the patient's expectations and, more importantly, the patient's willingness and ability to actively follow the treatment procedure. Fixed-dose combination of corticosteroid and vitamin D analogs is the preferred topical medication for both initial and maintenance phases of treatment. The fast containment of the disease is the goal of the initial phase of 4-8 weeks and it demands a potent fast-acting topical therapy. Satisfactory control of the disease and prevention of relapses should be achieved during the maintenance phase with twice a week or weekend applications.

KW - Asia

KW - Consensus

KW - Patient-centered care

KW - Psoriasis

KW - Topical therapy

UR - http://www.scopus.com/inward/record.url?scp=85046702306&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85046702306&partnerID=8YFLogxK

U2 - 10.1111/1346-8138.14338

DO - 10.1111/1346-8138.14338

M3 - Article

C2 - 29740870

AN - SCOPUS:85046702306

JO - Journal of Dermatology

JF - Journal of Dermatology

SN - 0385-2407

ER -